Teva Pharmaceutical Industries Ltd (TEVJF) — DEF 14A Filings
All DEF 14A filings from Teva Pharmaceutical Industries Ltd. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Teva Pharma Files DEF 14A on Executive Compensation
— Apr 9, 2025 Risk: medium
Teva Pharmaceutical Industries Ltd. filed its DEF 14A on April 9, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filin -
Teva Pharma's 2024 Shareholder Meeting: Growth & Innovation Focus
— Apr 16, 2024 Risk: medium
Teva Pharmaceutical Industries Ltd. is holding its 2024 Annual Meeting of Shareholders, as detailed in this DEF 14A filing. Chairman of the Board, Dr. Sol J. Ba
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX